Module 3: Zanubrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs, Anthony Mato, MD, MSCE
7:59
Chronic Lymphocytic Leukemia
Module 3: Zanubrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs, Anthony Mato, MD, MSCE
Chronic Lymphocytic Leukemia Similar Videos
Similar Videos
-
Module 5: Experts Debate Optimal Selection and Sequencing Strategies_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MD, MSCE
21:45
-
Recently presented data and optimal therapeutic approaches in relapsed/refractory CLL_Jennifer Brown, MD, PhD; #BeyondASCO
13:52
-
Susan O’Brien, MD; University of California Irvine; #DDHO2022
20:24
